Skip to main content
. 2022 Oct 31;13:862733. doi: 10.3389/fendo.2022.862733

Table 1.

Comparison of conditions in different ovarian response groups.

Low ovarian responsen = 441 Normal ovarian responsen = 1738 High ovarian responsen = 406 p-Value
Age (years) 37 (33-42) 31 (28-34) 29 (26-31) p < 0.05
BMI (kg/m2) 22.94
(20.89-24.98)
22.03▲
(20.03-24.24)
21.79▲
(20.03-23.87)
p < 0.05#
AMH (µg/l) 1.11
(0.47-1.80)
2.68
(1.42-4.68)
5.4
(3.14-8.31)
p < 0.05#
Natural cycles (%) 31 (7) 3 (0.2) 0 (0) p < 0.05#
Short protocols (%) 74 (16.8) 133 (7.6) 5 (1.2) p < 0.05#
Long protocols (%) 29 (7) 701 (40.3) 268 (66) p < 0.05#
Antagonist protocols (%) 147 (33.3) 818 (47.1) 132 (32.5) p < 0.05#
PPOS (%) 149 (33.8) 80 (4.6) 1 (0.2) p < 0.05#
Mild stimulation protocols (%) 11 (2.5) 3 (0.2) 0 (0) p < 0.05#
AFC (pieces) 5 (4-7) 12 (8-16) 16 (14-17) p < 0.05#
Gn medication days (d) 8 (7-9) 10 (9-12) 11 (10-12) p < 0.05#
Gn dosage (U) 2475 (1800-3225)★ 2550 (2025-3000)★ 1993.75 (1421.88-2625) p < 0.05
E2 on the hCG triggering day (pmol/l) 726.39
(376.48–1141.41)
2399.85
(1832.54–3307.17)
4421 (4184.74–5507.15) p < 0.05
Retrieved oocytes (pieces) 2 (1–3) 9 (6–12) 18 (17–19) p < 0.05
Available embryos (pieces) 1 (0–1) 4 (2–5) 7 (5–9) p < 0.05

LR, low ovarian response; NR, normal ovarian response; HR, high ovarian response.

BMI, body mass index, BMI = weight (kg)/height (m2); AMH, anti-Müllerian hormone; PPOS, progestin-primed ovarian stimulation; AFC, antral follicle count;

Gn: gonadotropin.

▲Group NR and group HR have no significant differences in BMI (p > 0.05).

Group LR and group NR have no significant differences in Gn dosage (p > 0.05).